Literature DB >> 12885452

The impact of sectional imaging on dose escalation in endocavitary HDR-brachytherapy of cervical cancer: results of a prospective comparative trial.

Natascha Wachter-Gerstner1, Stefan Wachter, Evi Reinstadler, Claudia Fellner, Tomas H Knocke, Richard Pötter.   

Abstract

PURPOSE: The purpose of this comparative prospective study was to assess the effect of CT and MR based individualisation and adaptation on the dose distribution in the target volume and organs at risk compared to a radiography based procedure.
MATERIAL AND METHODS: In 15 patients MR scans, in 10 patients additional axial CT-scans with compatible tube-ring applicator in situ were performed and digitally transferred to the PLATO(R) planning system. Considering clinical examination and MR-scan before radiotherapy individual 3-D dose distribution was calculated and adapted based on (1) two orthogonal radiographs; (2) isodoses superimposed on the CT images; and (3) isodoses superimposed on the MR images. Adaptation was strictly limited by the dose level at 2 cm(3) bladder or rectum volume (D(2)) to allow comparison of CT and MR plans. All three individualised dose distributions were superimposed on the MR images and cumulative dose-volume histograms were calculated for comparison.
RESULTS: 3-D individualisation based on sectional imaging enabled higher dose to the target volume (isodose enclosing 95% of the CTV=CTV(95)) compared to individualised treatment plans based on orthogonal radiographs by a mean factor of 1.2 (1-1.7). The dose to bladder and/or rectum wall was at the same time not increased beyond the prescribed tolerance level (71% of the prescribed target dose). In a subgroup of 10 patients MRI based treatment plans were superior to CT based treatment plans allowing for a higher dose (138% vs. 124%).
CONCLUSION: Sectional imaging based treatment planning, in particular using MR, was superior to radiography allowing for a clinical meaningful dose escalation without increasing the dose to bladder and rectum beyond the tolerance level.

Entities:  

Mesh:

Year:  2003        PMID: 12885452     DOI: 10.1016/s0167-8140(03)00083-5

Source DB:  PubMed          Journal:  Radiother Oncol        ISSN: 0167-8140            Impact factor:   6.280


  15 in total

1.  Late side effects of 3T MRI-guided 3D high-dose rate brachytherapy of cervical cancer : Institutional experiences.

Authors:  Radovan Vojtíšek; Emília Sukovská; Jan Baxa; Marie Budíková; Petra Kovářová; Jindřich Fínek
Journal:  Strahlenther Onkol       Date:  2019-07-15       Impact factor: 3.621

Review 2.  The future of image-guided radiotherapy will be MR guided.

Authors:  Julianne M Pollard; Zhifei Wen; Ramaswamy Sadagopan; Jihong Wang; Geoffrey S Ibbott
Journal:  Br J Radiol       Date:  2017-03-29       Impact factor: 3.039

3.  Assessment of tumor regression by consecutive pelvic magnetic resonance imaging and dose modification during high-dose-rate brachytherapy for carcinoma of the uterine cervix.

Authors:  Taek-Keun Nam; Byung-Sik Nah; Ho-Sun Choi; Woong-Ki Chung; Sung-Ja Ahn; Seok-Mo Kim; Ju-Young Song; Mi-Seon Yoon
Journal:  Cancer Res Treat       Date:  2005-06-30       Impact factor: 4.679

Review 4.  Brachytherapy in cancer cervix: Time to move ahead from point A?

Authors:  Anurita Srivastava; Niloy Ranjan Datta
Journal:  World J Clin Oncol       Date:  2014-10-10

Review 5.  Radiotherapy for cervical cancer: Chilean consensus of the Society of Radiation Oncology.

Authors:  Felipe Carvajal; Claudia Carvajal; Tomás Merino; Verónica López; Javier Retamales; Evelyn San Martín; Freddy Alarcón; Mónica Cuevas; Francisca Barahona; Ignacio Véliz; Juvenal A Ríos; Sergio Becerra
Journal:  Rep Pract Oncol Radiother       Date:  2021-04-14

6.  Dosimetric comparison of intensity-modulated, conformal, and four-field pelvic radiotherapy boost plans for gynecologic cancer: a retrospective planning study.

Authors:  Philip Chan; Inhwan Yeo; Gregory Perkins; Anthony Fyles; Michael Milosevic
Journal:  Radiat Oncol       Date:  2006-05-04       Impact factor: 3.481

Review 7.  The use of MRI in planning radiotherapy for gynaecological tumours.

Authors:  I Barillot; A Reynaud-Bougnoux
Journal:  Cancer Imaging       Date:  2006-06-22       Impact factor: 3.909

8.  Comparison of conventional and CT-based planning for intracavitary brachytherapy for cervical cancer: target volume coverage and organs at risk doses.

Authors:  Cem Onal; Gungor Arslan; Erkan Topkan; Berrin Pehlivan; Melek Yavuz; Ezgi Oymak; Aydin Yavuz
Journal:  J Exp Clin Cancer Res       Date:  2009-07-01

9.  Dosimetric and clinical outcomes of CT based HR-CTV delineation for HDR intracavitary brachytherapy in carcinoma cervix - a retrospective study.

Authors:  Anis Bandyopadhyay; Arnab Kumar Ghosh; Bappaditya Chhatui; Dhiman Das
Journal:  Rep Pract Oncol Radiother       Date:  2021-04-14

10.  Brachytherapy for cervix cancer: low-dose rate or high-dose rate brachytherapy - a meta-analysis of clinical trials.

Authors:  Gustavo A Viani; Gustavo B Manta; Eduardo J Stefano; Ligia I de Fendi
Journal:  J Exp Clin Cancer Res       Date:  2009-04-05
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.